Navigation Links
UCSF Launches Nationwide Clinical Trial Matching Web Site for Breast Cancer
Date:10/14/2008

SAN FRANCISCO, Oct. 14 /PRNewswire/ -- The University of California, San Francisco (UCSF) Center of Excellence for Breast Cancer Care today launched BreastCancerTrials.org, a free, non-profit, clinical trial matching service that provides nationwide information for individuals diagnosed with or at risk for breast cancer.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/breastcancerclinicaltrials/34846/

BreastCancerTrials.org is the only clinical trial matching service dedicated exclusively to breast cancer, with an online database that includes information about clinical trials taking place at more than 1100 medical facilities across the country. The site is an outgrowth of a successful regional pilot initiated by the UCSF Carol Franc Buck Breast Care Center, the National Cancer Institute (NCI) and patient advocates. The nationwide launch of BreastCancerTrials.org is made possible by a grant from The Safeway Foundation, the philanthropic arm of Safeway, Inc.

"BreastCancerTrials.org is an exciting, win-win development for the breast cancer community," said Laura Esserman, M.D., Director of the UCSF Center of Excellence for Breast Cancer Care and the UCSF Carol Franc Buck Breast Care Center. "Every advance in our understanding and treatment of breast cancer has come from clinical trial results. The more we can empower our patients to find out about and participate in trials, the faster we will be able to complete trials, and the sooner this new knowledge will translate into better care and outcomes for all patients."

By making information about trials easy to find, BreastCancerTrials.org hopes to make consideration of clinical trial participation the norm rather than the exception. By helping patients find and evaluate trials for which they may be eligible, and by encouraging and facilitating patient enrollment in trials, BreastCancerTrials.org intends to increase the rate at which new treatments and procedures are made available to all breast cancer patients, as well as those at heightened risk for developing the disease.

"I made the decision to enroll in a clinical trial because I wanted to explore all of my treatment options," said breast cancer survivor and BreastCancerTrials.org user Isabel Hemming of Los Angeles, California. "Through BreastCancerTrials.org, it was easy to find several trials that were seeking women with the type of breast cancer that I was diagnosed with, and -- after talking to my doctor -- I was able to identify one that I was eligible for. I hope that my participation in the trial may one day result in improved treatment for other women like me."

BreastCancerTrials.org users enter a detailed health history, which matches them to trials that are specific to their personal health situation. Information on whom to contact for further discussion about a trial and additional criteria for enrollment is also provided. Individuals can use BreastCancerTrials.org on a one-time basis or store their health history on secure servers for continual matching to newly listed trials. Information stored on BreastCancerTrials.org is never sold or shared with external parties.

According to the Clinical Research Roundtable at the Institute of Medicine, very few patients are currently aware that they are eligible for participation in research studies, making recruitment challenging for trial sites.(1) By helping individuals evaluate trials as a routine option for care, BreastCancerTrials.org hopes to increase the rate at which new treatments and procedures are developed and made available to individuals at all stages of their disease.

About BreastCancerTrials.org

BreastCancerTrials.org operates as an independent non-profit corporation.

BreastCancerTrials.org was initially co-developed as a regional pilot by the National Cancer Institute and the University of California, San Francisco Center of Excellence for Breast Cancer Care (COE-BCC), an integral program of the UCSF Carol Franc Buck Breast Care Center, and a core program of the UCSF National Center of Excellence in Women's Health and the UCSF Helen Diller Family Comprehensive Cancer Center. With the success of the pilot, BreastCancerTrials.org was incorporated as a separate non-profit corporation dedicated to the continuing delivery of this service.

For further information, visit the site at http://www.BreastCancerTrials.org.

About Breast Cancer

According to the American Cancer Society's Breast Cancer Facts & Figures 2007-2008, breast cancer is a progressive and potentially deadly disease that will affect about 182,460 women in 2008. About 40,480 women will die from breast cancer this year, and there are about 2.5 million breast cancer survivors in the United States. Additional research is critical and necessary to ensure that the millions affected by or at risk for breast cancer receive the proper treatment they need, according to ACS.

About the University of California, San Francisco

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For more information on UCSF, visit http://www.ucsf.edu.

(1) "Central Challenges Facing the National Clinical Research Enterprise." Journal of the American Medical Association, Vol 289, No. 10. March 12, 2003.


'/>"/>
SOURCE BreastCancerTrials.org
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... 2014. Each year, reproductive endocrinologists are required to report in vitro fertilization ... of professionals dedicated to the practice of assisted reproductive technologies in the United ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... le 27 Avril 2016 ... progressé de +5% sur le trimestre, soutenu par ... consommables  Croissance de +16% des ventes ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : ... laser, annonce aujourd,hui son chiffre d,affaires pour le ...
(Date:4/27/2016)... 27, 2016 Transparency Market Research ... Market - Global Industry Analysis, Size, Share, Growth, Trends, ... the global skincare devices market was valued at US$ ... at a CAGR of 10.1% from 2015 to 2023 ... Browse the full Skincare Devices Market (Treatment Device - LED ...
Breaking Medicine Technology: